| Homepage | Forward to a Friend | Make a Donation
|eLetter #684 | November 11, 2016
Cytori, Genentech to Present Scleroderma Research Trial Information at ACR Meeting
Therapeutics, Inc. will present data from its STAR
Phase 3 clinical trial describing progress, preliminary blinded patient
characteristics, and safety of adipose-derived regenerative cells
(ADRCs) for treatment of scleroderma hand dysfunction (clinicaltrials.gov)
at the Annual Meeting of the American College of Rheumatology on
November 15, 2016.
Read the full press release >>
Genentech, a member of the Roche Group announced that new data from Actemra (tocilizumab) and Rituxan
(rituximab) will be presented during the 2016 American College of
Rheumatology (ACR) and Association for Rheumatology Health Professionals
(ARHP) Annual Meeting, November 11-16, Washington, D.C. These data add
to the significant body of evidence for Actemra and Rituxan in RA and
other serious immune-mediated conditions including GCA, systemic
sclerosis (SSc), granulomatosis with polyangiitis (GPA) and microscopic
Learn more about this data >>
Meet the Scleroderma Foundation Staff at ACR
Members of the Scleroderma Foundation's National Office will be attending the ACR annual meeting November 11-16, 2016, in Washington, D.C. Please stop by booth No. 1241 in the Exhibit Hall.
Learn more about the ACR annual meeting >>
Simple Workout Routines for People with Chronic Pain
The Arthritis Foundation provides several different simple workout routines for people living with arthritis and chronic pain. These workouts include stretching, water aerobics, circuit training, weight lifting, and more.
Learn more about exercise routines >>
Video: Hematopoietic Stem Cell Transplants
In this video, Dr. Richard Burt talks about hematopoietic stem cell
transplantation as it relates to scleroderma. He also discusses
transplantation for autoimmune and immune mediated diseases.
Watch the entire session >>
Please consider a gift to
Foundation on November 29, 2016 in the spirit
of #GivingTuesday and help us #FUNDTHECURE!
You can help us continue the vital work of research by making a gift to
the Scleroderma Foundation.
We have a day for giving thanks. We
have two for getting deals. Now, we have #GivingTuesday, a global day dedicated
to giving back. On Tuesday, November 29, 2016,
charities, families, businesses, community centers, and students around the
world will come together for one common purpose: to celebrate generosity and to give.
#GivingTuesday challenges individuals
and communities to make the world a better place through generosity. The simple act of giving not only helps
others, but also fundamentally connects you to the human family and nourishes a
generous community spirit.
Making your gift is easy!
Visit www.scleroderma.org/givingtuesday or call us at 800-722-HOPE (4673).
Disclaimer: The Scleroderma Foundation in no way
endorses any drugs, treatments, clinical trials, or studies reported in the eLetter. Information is
provided to keep the readers informed. Because the manifestations and severity of scleroderma vary among individuals, personalized medical management is essential. Therefore, it is strongly recommended that all drugs and treatments be discussed with the reader’s physician(s) for proper evaluation and treatment.